• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.69% Nasdaq Down1.07%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.44 Up 0.03(7.24%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development2,237  1,999  1,323  1,486  
    Selling General and Administrative1,151  1,103  916  957  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,388) (3,101) (2,239) (2,444)
    Income from Continuing Operations
    Total Other Income/Expenses Net233  1,765  140  564  
    Earnings Before Interest And Taxes(3,155)(1,336)(2,099)(1,880)
    Interest Expense -  89  29  9  
    Income Before Tax(3,155)(1,425)(2,127)(1,889)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,155)(1,425)(2,127)(1,889)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,155) (1,425) (2,127) (1,889)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,155) (1,425) (2,127) (1,889)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.